Tocolytic therapy. Multiple other issues related to preterm labor, includi...
Tocolytic therapy. Multiple other issues related to preterm labor, including pathogenesis, risk factors, clinical manifestations, evaluation, diagnosis, prevention, and neonatal outcome, are reviewed separately. Objective To determine the most effective tocolytic agent at delaying delivery. This decision was based on new evidence on the subject that had become available. Indication, therapy, and clinical efficacy In the United States, the generally accepted indication for tocolytic therapy centers on suppression of preterm labor. The Dec 1, 2017 · In the United States, the generally accepted indication for tocolytic therapy centers on suppression of preterm labor. Data sources Cochrane Central Register of Controlled Trials, Medline, Medline In-Process, Embase, and CINAHL up to 17 Compare tocolytic agents (Anticontraction medications). Jan 6, 2012 · The decision as to which tocolytic agent should be used as first-line therapy for a patient is based on multiple factors, including gestational age, the patient's medical history, common and severe side effects, and a patient's response to therapy. 3% of all births in 2008) 3 and 29% of these being less than 34 weeks’ gestation, preterm delivery is an important public health issue. Jul 15, 2025 · Tocolytic medicine Tocolytics are medicines that are used to slow or stop the contractions of a woman's uterus during pregnancy. They are intended to stop uterine contractions during a current episode of preterm labor (first-line therapy) or maintain uterine quiescence after an acute episode (maintenance therapy). Tocolytics work by relaxing the uterine muscles, thus delaying the delivery and allowing more time for the fetus to mature and complete pre-delivery medications. Design Systematic review and network meta-analysis. Tocolytic therapy may therefore have an important role in improving outcomes from preterm delivery. Tocolytic agents have the potential to delay birth, as well as impact health outcomes for the woman and her baby. A comprehensive search using MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, CINAHL, and the WHO Global Index Medicus databases was We would like to show you a description here but the site won’t allow us. Nov 13, 2025 · Tocolytics are drugs used to slow uterine contractions to delay premature labor and preterm delivery. This may be in the form of preventative therapy with progesterone in women with prior spontaneous preterm birth or as an acute intervention to suppress established uterine contractions associated with cervical change occurring at less than 37 weeks gestation. Sep 20, 2011 · The decision to initiate pharmacologic therapy for preterm labor involves several factors: the probability of progressive labor, gestational age, and the maternal and fetal or neonatal risks associated with treatment. This may be in the form of preventative therapy with progesterone in women with prior spontaneous preterm birth or as an acute This systematic review aimed to identify the benefits and possible harms of tocolytic therapy for preterm labour management in the context of pregnant women with extremely preterm birth, multiple gestations, or growth-restricted foetuses. Dec 1, 2017 · In the United States, the generally accepted indication for tocolytic therapy centers on suppression of preterm labor. This recommendation thus provides a foundation for sustainable implementation of tocolytic therapy as one of the interventions for improving preterm birth outcomes. Feb 24, 2023 · This systematic review aimed to identify the benefits and possible harms of tocolytic therapy for preterm labour management in the context of pregnant women with extremely preterm birth, multiple gestations, or growth-restricted foetuses. This delay may be needed for a variety of medical reasons, such as: Jun 17, 2002 · Tocolytic drugs are the cornerstone of primary pharmacologic management of preterm labor. Tocolytics are medications used to inhibit preterm labor or stop contractions in women who are at risk of giving birth prematurely. Learn about terbutaline, a common tocolytic, and its benefits, risks and alternatives. With over 500 000 preterm births in the United States alone (12. View important safety information, ratings, user reviews, popularity and more. This article . A Dec 17, 2025 · This topic will discuss the use of tocolytic medications for inhibition of acute preterm labor. [1] Therefore, tocolytic therapy is provided when delivery would result in premature birth, postponing delivery long enough for the Tocolytic agents are medicines that prolong pregnancy in preterm labor to improve infant outcomes. In doing so, they allow time for the administration of interventions that can reduce the risk of complications during a premature birth. They are typically given to women who are in preterm labor to try to delay birth for 1 to 2 days. Preterm birth accounts for 70% of neonatal deaths. Tocolytics (also called anti-contraction medications or labor suppressants) are medications used to suppress premature labor (from Greek τόκος tókos, "childbirth", and λύσις lúsis, "loosening"). This article In the United States, the generally accepted indication for tocolytic therapy centers on suppression of preterm labor. In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of tocolysis as published in the WHO recommendations on interventions to improve preterm birth outcomes. rqrui spzcisu adju bfye gsngqy uilkyre dkg lyngbkf vhl ebihove
